Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-23 5:08 pm Sale | 2025-06-18 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 1,453 1.000% | -7,956![]() (-84.56%) | Filing History |
| 2025-06-23 5:06 pm Sale | 2025-06-18 | 13D | CHEMOMAB THERAPEUTICS LTD CMMB | OrbiMed Israel BioFund GP Limited Partnership | 242,452 4.800% | -222,774![]() (-47.89%) | Filing History |
| 2024-09-16 4:34 pm Sale | 2024-09-12 | 13D | CHEMOMAB THERAPEUTICS LTD CMMB | OrbiMed Israel BioFund GP Limited Partnership | 465,226 9.990% | -102,297![]() (-18.03%) | Filing History |
| 2024-07-17 8:40 pm Purchase | 2024-07-15 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 9,409 9.990% | 2,789![]() (+42.13%) | Filing History |
| 2024-03-19 9:11 pm Purchase | 2024-03-15 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 6,620 19.900% | 4,198![]() (+173.33%) | Filing History |
| 2024-03-11 7:19 pm Unchanged | 2024-03-11 | 13D | CHEMOMAB THERAPEUTICS LTD CMMB | OrbiMed Israel BioFund GP Limited Partnership | 567,523 16.000% | 0 (Unchanged) | Filing History |
| 2024-03-08 4:30 pm Purchase | 2024-03-06 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 2,422 9.900% | 25![]() (+1.04%) | Filing History |
| 2023-11-15 4:35 pm Unchanged | 2023-11-14 | 13D | CHEMOMAB THERAPEUTICS LTD CMMB | OrbiMed Israel BioFund GP Limited Partnership | 567,523 18.300% | 0 (Unchanged) | Filing History |
| 2023-05-08 4:43 pm Purchase | 2023-05-04 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 2,397 9.900% | 536![]() (+28.80%) | Filing History |
| 2023-03-17 4:19 pm Purchase | 2023-02-27 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 1,861 10.500% | 655![]() (+54.31%) | Filing History |
| 2023-01-05 4:31 pm Sale | 2023-01-03 | 13D | CHEMOMAB THERAPEUTICS LTD CMMB | OrbiMed Israel BioFund GP Limited Partnership | 567,523 19.700% | -12,467,432![]() (-95.65%) | Filing History |
| 2022-07-01 5:20 pm Sale | 2022-07-01 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 12,356,873 4.600% | -3,027,545![]() (-19.68%) | Filing History |

